More tools:Markets·Screener·Research·Chat

Autolus Therapeutics plc American Depositary Share (AUTL) Financial Statements

Autolus Therapeutics plc American Depositary Share
SIC 2836 · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
FIGI BBG00KVT06G6
XNAS · usd
2.11▼ 0.13 (-5.80%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close2.24
Day's Range2.10 – 2.23
52-Week Range1.18 – 2.58
Volume2.6M
Avg Volume2.8M
Share Statistics
Shares Outstanding
Employees752
ExchangeXNAS
Listed2018-06-22
Share count as of August 10, 2026
Loading Income Statement…
Key questions about Autolus Therapeutics plc American Depositary Share (AUTL)
What is Autolus Therapeutics plc American Depositary Share's Market Cap?
Autolus Therapeutics plc American Depositary Share's Market Cap is $561.6M, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's Enterprise Value?
Autolus Therapeutics plc American Depositary Share's Enterprise Value is $390.2M, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's Price / Sales?
Autolus Therapeutics plc American Depositary Share's Price / Sales is 4.8×, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's EV / Revenue?
Autolus Therapeutics plc American Depositary Share's EV / Revenue is 3.3×, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's EV / EBITDA?
Autolus Therapeutics plc American Depositary Share's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's Revenue (TTM)?
Autolus Therapeutics plc American Depositary Share's Revenue (TTM) is $117.4M, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's Net Income (TTM)?
Autolus Therapeutics plc American Depositary Share's Net Income (TTM) is -$280.2M, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's EBITDA?
Autolus Therapeutics plc American Depositary Share's EBITDA is -$238.8M, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's Diluted EPS (TTM)?
Autolus Therapeutics plc American Depositary Share's Diluted EPS (TTM) is -1.05, based on as-reported figures from SEC (XBRL) filings.
What is Autolus Therapeutics plc American Depositary Share's EBITDA Margin?
Autolus Therapeutics plc American Depositary Share's EBITDA Margin is -203.5%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Total revenue, net
YoY growth+118.4%+191.9%+83655.2%—
Cost and operating expenses:
Cost of sales
Research and development expenses, net
Selling, general and administrative expenses
Loss from operations
% of revenue-95.9%-227.0%-298.3%-337.9%
Other income (expense):
Other income, net
Foreign exchange gains (losses), net
Interest income
Interest expense, net
Total other income (expenses), net
Net loss before income tax
Net loss
% of revenue-85.6%-273.1%-371.9%-373.3%
Basic net loss per ordinary share (in usd per share)
Diluted net loss per ordinary share (in usd per share)